J&J appoints Eugene Washington to board
This article was originally published in Scrip
Johnson & Johnson has elected Dr Eugene Washington to its board of directors. Dr Washington is vice-chancellor of health sciences and dean of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), as well as CEO of the UCLA Health System and a professor of gynecology and health policy at UCLA. He also serves as chair of the board of governors of the Patient-Centered Outcomes Research Center for Diverse Populations, and a board member of the California Wellness Foundation.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.